Amended Tender Offer Statement by Third Party (sc To-t/a)
08 Noviembre 2017 - 3:54PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment
No. 3
to
SCHEDULE TO
(Rule
14d-100)
Tender Offer Statement under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
CombiMatrix Corporation
(Name of Subject Company (Issuer))
Invitae Corporation
(Name of Filing Person (Offeror))
Series F Warrants to Purchase Common Stock, Par Value $0.001 Per Share
(Title of Class of Securities)
20009T147
(CUSIP Number
of Class of Securities)
Sean E. George, Ph.D.
President and Chief Executive Officer
Invitae Corporation
1400
16th Street
San Francisco, CA 94103
(415)
374-7782
(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)
Copies to:
|
|
|
|
|
|
|
Thomas Brida
General Counsel
Invitae Corporation
1400 16th Street
San Francisco, CA 94103
(415)
374-7782
|
|
Mike Hird
Patty M. DeGaetano
Pillsbury Winthrop Shaw Pittman LLP
12255 El Camino Real, Suite 300
San Diego, CA 92130
(619)
234-5000
|
|
Mark McDonough
President and
Chief Executive Officer
CombiMatrix Corporation
300 Goddard, Suite 100
Irvine, CA 92618
(949)
753-0624
|
|
Parker A. Schweich
Stradling Yocca
Carlson & Rauth, P.C.
660 Newport Center Drive,
Suite 1600
Newport Beach, CA 92660
(949)
725-4000
|
☐
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
Check the appropriate boxes below to designate any transactions to which the statement relates:
|
☒
|
third party tender offer subject to Rule
14d-1.
|
|
☐
|
issuer tender offer subject to Rule
13e-4.
|
|
☐
|
going-private transaction subject to Rule
13e-3.
|
|
☐
|
amendment to Schedule 13D under Rule
13d-2.
|
Check the
following box if the filing is a final amendment reporting the results of the tender offer: ☐
If applicable, check the
following box(es) below to designate the appropriate rule provision(s) relied upon:
|
☐
|
Rule
13e-4(i)
(Cross-Border Issuer Tender Offer)
|
|
☐
|
Rule
14d-1(d)
(Cross-Border Third-Party Tender Offer)
|
This Amendment No. 3 (this Amendment) amends and supplements the Tender Offer Statement on
Schedule TO (as amended, the Schedule TO) originally filed by Invitae Corporation, a Delaware corporation (Invitae), on September 13, 2017, as subsequently amended by Amendment No. 1 to the Schedule TO filed with
the Securities and Exchange Commission (the SEC) on September 28, 2017 and Amendment No. 2 to the Schedule TO filed with the SEC on October 23, 2017. This Schedule TO relates to the offer by Invitae to exchange (the
Exchange Offer) each outstanding Series F warrant (the CombiMatrix Series F Warrants) to acquire shares of common stock of CombiMatrix Corporation (CombiMatrix) for shares of common stock, par value $0.0001 per
share, of Invitae (the Invitae Common Stock). The terms and conditions of the Exchange Offer and procedures for tendering the CombiMatrix Series F Warrants are set forth in the prospectus/offer to exchange, dated October 6, 2017
(the Prospectus/Offer to Exchange), as supplemented by Prospectus Supplement No. 1, dated October 23, 2017, filed as Exhibit (a)(4)(B) hereto (the Prospectus Supplement), and in the related letter of transmittal
(the Letter of Transmittal).
On October 5, 2017, the SEC declared effective Invitaes registration statement on Form
S-4
(No.
333-220448)
(as amended, the Registration Statement), relating to the Exchange Offer. The terms and conditions of the Exchange Offer, as well as a
description of Invitae and other information required by Schedule TO, are set forth in the Prospectus/Offer to Exchange and the Letter of Transmittal, which is filed as Exhibit 99.1 to the Registration Statement, as supplemented by the Prospectus
Supplement.
Pursuant to the Exchange Offer, each CombiMatrix Series F Warrant validly tendered and not withdrawn in the Exchange Offer will be exchanged
for a number of shares of Invitae Common Stock (the Warrant Exchange Ratio) equal to 0.3056, which was calculated as the quotient (rounded to the nearest
ten-thousandth)
obtained by dividing $2.90
by the average closing price of $9.491 for shares of Invitae common stock on the NYSE for the immediately preceding period of 30 trading days prior to July 31, 2017, the date of the Agreement and Plan of Merger and Reorganization (the
Merger Agreement) by and among Invitae, Coronado Merger Sub, Inc., a wholly owned subsidiary of Invitae (Merger Sub), and CombiMatrix, pursuant to which Merger Sub will merge with and into CombiMatrix, with CombiMatrix
surviving as a wholly owned subsidiary of Invitae (the Merger).
On November 8, 2017, Invitae issued a press release, filed as Exhibit
(a)(1)(F) hereto, reminding CombiMatrix Series F Warrant holders about the Exchange Offer expiration, its terms, conditions, the intended delisting of any unexchanged and unexercised CombiMatrix Series F Warrants, and procedures for tendering or
exercising their CombiMatrix Series F Warrants.
Items 1 through 9, and Item 11.
All of the information in the Prospectus/Offer to Exchange, the Prospectus Supplement, and any additional prospectus supplement or other amendment or
supplement thereto related to the Exchange Offer hereafter filed with the SEC by Invitae, is hereby incorporated by reference into Items 1 through 9 and 11 of this Schedule TO. This Amendment should be read together with the Schedule TO.
Item 10. Financial Statements.
The information set
forth in the Prospectus/Offer to Exchange under the sections entitled
Selected Historical Financial Data of Invitae
,
Selected Historical Financial Data of CombiMatrix
,
Unaudited Pro Forma Condensed
Combined Financial Information
and
Where You Can Find More Information
is incorporated herein by reference.
Item 12. Exhibits.
|
|
|
Exhibit No.
|
|
Description
|
|
|
(a)(1)(A)*
|
|
Form of Letter of Transmittal.
|
|
|
(a)(1)(B)*
|
|
Internal Revenue Service Form
W-9
(included in Exhibit (a)(1)(A)).
|
|
|
(a)(1)(C)*
|
|
Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.
|
|
|
(a)(1)(D)*
|
|
Form of Letter to Clients.
|
|
|
(a)(1)(E)*
|
|
Form of Notice of Guaranteed Delivery.
|
|
|
(a)(1)(F)
|
|
Press release issued by Invitae Corporation on November 8, 2017.
|
|
|
(a)(2)
|
|
Not applicable.
|
|
|
(a)(3)
|
|
Not applicable.
|
|
|
(a)(4)(A)
|
|
Prospectus/Offer to Exchange relating to shares of common stock of Invitae Corporation to be issued in the Exchange Offer (incorporated by reference to the Prospectus/Offer to Exchange filed by Invitae Corporation with the SEC on
October 6, 2017).
|
|
|
(a)(4)(B)
|
|
Prospectus Supplement No. 1 to the Prospectus/Offer to Exchange relating to shares of common stock of Invitae Corporation to be issued in the Exchange Offer (incorporated by reference to Prospectus Supplement No. 1 filed
by Invitae Corporation with the SEC on October 23, 2017).
|
|
|
(a)(5)
|
|
Not applicable.
|
|
|
(b)
|
|
Not applicable.
|
|
|
(d)(1)*
|
|
Agreement and Plan of Merger and Reorganization, dated as of July 31, 2017, by and among Invitae Corporation, Coronado Merger Sub, Inc. and CombiMatrix Corporation (incorporated by reference to Exhibit 2.1 to Invitaes
Current Report on Form
8-K
filed on August 1, 2017, and included as Annex A to Exhibit (a)(4)(A)).
|
|
|
(d)(2)*
|
|
Form of Transaction Bonus Payout Agreement, dated as of July 31, 2017, entered into by and among CombiMatrix Corporation, Invitae Corporation and each of the outside directors of CombiMatrix.
|
|
|
(d)(3)*
|
|
Transaction Bonus Payout Agreement, dated as of July 31, 2017, by and among Invitae Corporation, CombiMatrix Corporation and Mark McDonough.
|
|
|
(d)(4)*
|
|
Transaction Bonus Payout Agreement, dated as of July 31, 2017, by and among Invitae Corporation, CombiMatrix Corporation and Scott R. Burell.
|
|
|
(d)(5)*
|
|
Independent Contractor Agreement, effective as of the closing of the Merger, by and between Invitae Corporation and Mark McDonough.
|
|
|
(d)(6)*
|
|
Independent Contractor Agreement, effective as of the closing of the Merger, by and between Invitae Corporation and Scott R. Burell.
|
|
|
(d)(7)
|
|
Marketing and Laboratory Services Agreement, dated as of September 25, 2017, by and among Invitae Corporation, Good Start Genetics, Inc. and CombiMatrix Molecular Diagnostics, Inc. (incorporated by reference to Exhibit 10.1 to
Invitaes Current Report on Form
8-K
filed on September 27, 2017).
|
|
|
(g)
|
|
Not applicable.
|
|
|
(h)(i)*
|
|
Legal Opinion of Pillsbury Winthrop Shaw Pittman LLP regarding tax matters.
|
|
|
(h)(ii)*
|
|
Legal Opinion of Stradling Yocca Carlson & Rauth, P.C. regarding tax matters.
|
*
|
Incorporated by reference to the Registration Statement.
|
Item 13. Information Required By Schedule
13E-3.
Not applicable.
SIGNATURES
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|
INVITAE CORPORATION
|
|
|
|
|
Dated: November 8, 2017
|
|
|
|
By:
|
|
/s/ Shelly D. Guyer
|
|
|
|
|
Name:
|
|
Shelly D. Guyer
|
|
|
|
|
Title:
|
|
Chief Financial Officer
|
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024